tradingkey.logo

West Pharmaceutical Services Inc

WST

209.483USD

-1.807-0.86%
交易中 美东报价延迟15分钟
15.04B总市值
30.53市盈率 TTM

West Pharmaceutical Services Inc

209.483

-1.807-0.86%
关于 West Pharmaceutical Services Inc 公司
West Pharmaceutical Services, Inc. 是一家全球制造商,致力于设计和生产技术先进的注射药物和保健产品集成容器和输送系统。公司通过两个部门运营:专有产品和合同制造产品。专有产品部门主要向生物、仿制药和制药客户提供包装、容器解决方案和药物输送产品,以及分析实验室服务和其他集成服务和解决方案。合同制造产品部门是一家完全整合的企业,专注于复杂设备的设计、制造和自动化组装,主要面向制药、诊断和医疗设备客户。该部门制造用于外科、诊断、眼科、注射和其他药物输送系统以及消费产品的客户自有组件和设备。
公司简介
公司代码WST
公司名称West Pharmaceutical Services Inc
上市日期Jul 27, 1923
成立日期1923
CEOMr. Eric Mark Green
员工数量10600
证券类型Ordinary Share
年结日Jul 27
公司地址530 Herman O. West Drive
城市EXTON
上市交易所NYSE Consolidated
国家United States of America
邮编19341
电话16105942900
网址https://www.westpharma.com/
公司代码WST
上市日期Jul 27, 1923
成立日期1923
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
43.90K
+0.43%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
41.87K
+0.43%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
41.73K
+0.42%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
17.94K
+0.61%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
9.39K
+0.88%
Mr. Bernard John Birkett
Mr. Bernard John Birkett
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.54K
+9.37%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
3.07K
+2.06%
Ms. Kimberly Banks Mackay
Ms. Kimberly Banks Mackay
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
1.51K
+11.48%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
43.90K
+0.43%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
41.87K
+0.43%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
41.73K
+0.42%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
17.94K
+0.61%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
地区USD
名称
营收
占比
United States
1.23B
42.54%
Other European Countries
385.50M
13.32%
Germany
372.50M
12.88%
Other
339.00M
11.72%
Ireland
323.20M
11.17%
France
242.20M
8.37%
业务
地区
业务USD
名称
营收
占比
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
12.47%
BlackRock Institutional Trust Company, N.A.
5.76%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.52%
Artisan Partners Limited Partnership
4.33%
Other
68.38%
持股股东
股东统计
占比
The Vanguard Group, Inc.
12.47%
BlackRock Institutional Trust Company, N.A.
5.76%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.52%
Artisan Partners Limited Partnership
4.33%
Other
68.38%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
48.42%
Investment Advisor
36.64%
Hedge Fund
4.18%
Pension Fund
3.86%
Research Firm
2.00%
Bank and Trust
1.66%
Sovereign Wealth Fund
1.28%
Insurance Company
0.78%
Individual Investor
0.59%
Other
0.58%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
1612
71.77M
99.89%
-1.14M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
2023Q1
1586
71.76M
96.63%
-2.52M
2022Q4
1564
71.37M
96.40%
-822.34K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
8.96M
12.39%
-463.00
-0.01%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.14M
5.72%
-38.26K
-0.92%
Dec 31, 2024
Brown Advisory
2.55M
3.53%
+266.49K
+11.66%
Dec 31, 2024
State Street Global Advisors (US)
3.25M
4.49%
+32.27K
+1.00%
Dec 31, 2024
Artisan Partners Limited Partnership
3.11M
4.3%
+44.38K
+1.45%
Dec 31, 2024
AllianceBernstein L.P.
2.59M
3.59%
-11.06K
-0.42%
Dec 31, 2024
Walter Scott & Partners Ltd.
2.42M
3.34%
+40.48K
+1.70%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.78M
2.46%
+38.76K
+2.23%
Dec 31, 2024
Franklin Advisers, Inc.
1.75M
2.42%
-502.73K
-22.29%
Dec 31, 2024
APG Asset Management N.V.
1.44M
1.99%
-871.45K
-37.74%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Amplify Weight Loss Drug & Treatment ETF
3.12%
VanEck Morningstar Wide Moat Growth ETF
2.93%
VictoryShares THB Mid Cap ESG ETF
2.42%
VanEck Morningstar Wide Moat ETF
2.08%
American Century Mid Cap Growth Impact ETF
1.5%
Nuveen ESG Mid-Cap Growth ETF
1.41%
Goldman Sachs Future Health Care Equity ETF
1.36%
Invesco S&P 500 Equal Weight Health Care ETF
1.16%
Nuveen ESG Mid-Cap Value ETF
1.13%
Invesco Nasdaq Free Cash Flow Achievers ETF
1.1%
查看更多
Amplify Weight Loss Drug & Treatment ETF
占比3.12%
VanEck Morningstar Wide Moat Growth ETF
占比2.93%
VictoryShares THB Mid Cap ESG ETF
占比2.42%
VanEck Morningstar Wide Moat ETF
占比2.08%
American Century Mid Cap Growth Impact ETF
占比1.5%
Nuveen ESG Mid-Cap Growth ETF
占比1.41%
Goldman Sachs Future Health Care Equity ETF
占比1.36%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.16%
Nuveen ESG Mid-Cap Value ETF
占比1.13%
Invesco Nasdaq Free Cash Flow Achievers ETF
占比1.1%
分红派息
近5年累计派现 269.40M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Mar 03, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on May 03, 2023 going ex on Apr 25, 2023
Apr 26, 2023
May 03, 2023
Apr 25, 2023
Dec 13, 2022
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Feb 01, 2023 going ex on Jan 24, 2023
Jan 25, 2023
Feb 01, 2023
Jan 24, 2023
Oct 27, 2022
WST.NB Final Cash Dividend of gross USD 0.19 paid on Nov 16, 2022 going ex on Nov 08, 2022
Nov 09, 2022
Nov 16, 2022
Nov 08, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有